InfuSystem Announces Distribution Agreement with Genadyne for Negative Pressure Wound Therapy Systems

ROCHESTER HILLS, Michigan—InfuSystem Holdings, Inc., a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced a national distribution agreement with Genadyne Biotechnologies Inc. for its negative pressure wound therapy (NPWT) systems and supplies.

InfuSystem will offer Genadyne’s complete line of wound care products, including its most advanced XLR8 Plus NPWT Pump, which delivers advanced variable pressure capabilities with a gradual wave, in conjunction with Genadyne’s proprietary XLR8 Dressing Kit with Silver, an antimicrobial contact layer to protect the wound.

“We are pleased to partner with Genadyne in providing our customers with access to their advanced negative pressure wound therapy systems and supplies,” said Richard DiIorio, chief executive officer of InfuSystem. “These products are manufactured in the U.S. This agreement represents a second NPWT device offering that will help to mitigate supply chain issues and provide our customers with multiple options. Our goal through our SI Wound Care partnership is to provide our patients and partners with a seamless offering of unique wound care products to promote healing, improve patient outcomes and lower the cost of care. We look forward to a long and mutually beneficial relationship.”